We are live on ! Find out more
MBIO icon

Mustang Bio

17 hedge funds and large institutions have $70.9K invested in Mustang Bio in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

6% more funds holding

Funds holding: 1617 (+1)

3.86% less ownership

Funds ownership: 5.96%2.1% (-3.9%)

50% less capital invested

Capital invested by funds: $142K → $70.9K (-$71.4K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MBIO Hedge Fund Activity: Q2 2025 in Review

17 of the 7,602 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2025, worth a combined $70.9K — down 50% from $142K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MBIO positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $34K. The largest seller was Anson Funds Management, exiting entirely with an estimated $57.1K sold.

  • 17 institutional investors held Mustang Bio (MBIO) as of Q2 2025, up from 16 in Q1 2025.
  • Funds reported $70.9K of Mustang Bio stock for Q2 2025, down 50% quarter-over-quarter.
  • 3 funds opened new Mustang Bio positions in Q2 2025 and 2 closed out, a net change of +1 holder.
  • The largest Mustang Bio buyer in Q2 2025 was Citadel Advisors, an estimated $34K added.
  • The largest Mustang Bio seller in Q2 2025 was Anson Funds Management, an estimated $57.1K sold.

Based on aggregated 13F filings for Q2 2025.